Your browser is no longer supported. Please, upgrade your browser.
MRNA [NASD]
Moderna, Inc.
IndexS&P 500 P/E53.69 EPS (ttm)8.01 Insider Own2.40% Shs Outstand402.00M Perf Week0.02%
Market Cap183.50B Forward P/E15.72 EPS next Y27.37 Insider Trans-33.70% Shs Float364.63M Perf Month8.11%
Income3.49B PEG3.20 EPS next Q9.44 Inst Own58.00% Short Float3.92% Perf Quarter95.57%
Sales7.02B P/S26.14 EPS this Y-26.10% Inst Trans7.25% Short Ratio0.78 Perf Half Y222.73%
Book/sh16.68 P/B25.79 EPS next Y-7.99% ROA34.20% Target Price306.31 Perf Year560.03%
Cash/sh18.73 P/C22.97 EPS next 5Y16.80% ROE88.10% 52W Range63.64 - 497.49 Perf YTD311.74%
Dividend- P/FCF20.20 EPS past 5Y- ROI-28.40% 52W High-13.54% Beta-
Dividend %- Quick Ratio1.20 Sales past 5Y- Gross Margin86.50% 52W Low575.90% ATR23.18
Employees1300 Current Ratio1.20 Sales Q/Q6398.50% Oper. Margin54.40% RSI (14)54.01 Volatility4.70% 5.35%
OptionableYes Debt/Eq0.07 EPS Q/Q- Profit Margin49.80% Rel Volume0.71 Prev Close454.60
ShortableYes LT Debt/Eq0.05 EarningsAug 05 BMO Payout0.00% Avg Volume18.34M Price430.14
Recom2.70 SMA202.36% SMA5010.26% SMA20095.36% Volume12,984,587 Change-5.38%
Aug-06-21Downgrade Piper Sandler Overweight → Neutral $246 → $445
Aug-06-21Downgrade Oppenheimer Outperform → Perform
Jul-15-21Reiterated Jefferies Hold $170 → $250
Feb-01-21Downgrade BofA Securities Neutral → Underperform
Dec-16-20Downgrade Morgan Stanley Overweight → Equal-Weight $150
Dec-16-20Downgrade Jefferies Buy → Hold $90 → $150
Dec-09-20Downgrade Needham Buy → Hold
Nov-23-20Initiated Wells Fargo Equal Weight $92
Nov-17-20Downgrade BMO Capital Markets Outperform → Market Perform $109
Sep-08-20Downgrade SVB Leerink Mkt Perform → Underperform $58 → $41
Jul-23-20Initiated SVB Leerink Mkt Perform
Jul-20-20Downgrade JP Morgan Overweight → Neutral $89
Jul-13-20Initiated Jefferies Buy $90
Jun-30-20Initiated Argus Buy $80
Jun-08-20Initiated Barclays Overweight $68
Apr-30-20Initiated BMO Capital Markets Outperform $83
Mar-05-20Downgrade BofA/Merrill Buy → Neutral $32
Dec-03-19Resumed BofA/Merrill Buy
Oct-25-19Initiated ROTH Capital Buy $24
Apr-05-19Initiated Chardan Capital Markets Buy $40
Sep-26-21 09:00AM  
08:55AM  
Sep-25-21 02:06PM  
07:00AM  
Sep-24-21 04:26PM  
02:07PM  
02:02PM  
01:27PM  
01:06PM  
12:20PM  
11:30AM  
11:27AM  
11:15AM  
10:37AM  
10:17AM  
09:40AM  
08:19AM  
06:05AM  
06:00AM  
Sep-23-21 09:33PM  
12:06PM  
08:16AM  
07:50AM  
06:44AM  
06:20AM  
06:00AM  
06:00AM  
05:52AM  
01:29AM  
01:00AM  
Sep-22-21 09:08PM  
08:38PM  
05:45PM  
03:25PM  
01:43PM  
01:40PM  
11:44AM  
08:00AM  
06:00AM  
05:52AM  
Sep-21-21 11:33PM  
05:57PM  
05:31PM  
03:04PM  
01:18PM  
10:30AM  
09:09AM  
07:00AM  
Sep-20-21 04:50PM  
04:09PM  
03:57PM  
03:54PM  
03:29PM  
02:23PM  
01:42PM  
10:38AM  
10:00AM  
09:48AM  
08:16AM  
05:52AM  
Sep-19-21 01:29PM  
12:29PM  
07:11AM  
06:04AM  
06:00AM  
Sep-18-21 06:45AM  
Sep-17-21 06:04PM  
04:41PM  
04:26PM  
03:59PM  
03:56PM  
03:34PM  
02:29PM  
02:09PM  
01:50PM  
12:22PM  
12:07PM  
11:34AM  
11:17AM  
07:00AM  
Sep-16-21 05:45PM  
05:29PM  
05:19PM  
04:43PM  
04:15PM  
03:38PM  
03:08PM  
12:53PM  
12:13PM  
12:10PM  
10:54AM  
10:36AM  
10:24AM  
09:51AM  
06:40AM  
06:06AM  
05:20AM  
04:26AM  
03:57AM  
02:06AM  
Moderna, Inc., a biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases. As of March 9, 2021, the company had 13 programs in clinical trials and a total of 24 development programs in six modalities comprising prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted and cell surface therapeutics, and systemic intracellular therapeutics. The company has strategic alliances with AstraZeneca PLC, Merck & Co., Inc., Vertex Pharmaceuticals Incorporated, Vertex Pharmaceuticals (Europe) Limited, the Biomedical Advanced Research and Development Authority, the Defense Advanced Research Projects Agency, the National Institute of Allergy and Infectious Diseases, the National Institutes of Health, the Coalition for Epidemic Preparedness Innovations, and Bill & Melinda Gates Foundation. Moderna, Inc. also has collaborations with Lonza Ltd. for the manufacture of COVID-19 vaccine; and Catalent Inc., Laboratorios Farmaceuticos Rovi, S.A., Recipharm, and Lonza Group for fill-finish manufacturing of its COVID-19 vaccine candidate, as well as Aldevron, LLC for supporting COVID-19 vaccine and additional programs in company's clinical development pipeline. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bancel StephaneChief Executive OfficerSep 23Sale439.4510,0004,394,5007,224,880Sep 24 04:17 PM
Andres JuanSee remarksSep 22Option Exercise12.215,00061,0505,000Sep 24 04:09 PM
Andres JuanSee remarksSep 22Sale433.005,0002,165,0000Sep 24 04:09 PM
Bancel StephaneChief Executive OfficerSep 22Sale433.009,0003,897,0006,087,868Sep 24 04:17 PM
Andres JuanSee remarksSep 20Option Exercise12.215,00061,0505,000Sep 21 04:17 PM
Andres JuanSee remarksSep 20Sale417.625,0002,088,1000Sep 21 04:17 PM
Andres JuanSee remarksSep 17Option Exercise12.215,00061,0505,000Sep 21 04:17 PM
Andres JuanSee remarksSep 17Sale438.245,0002,191,2000Sep 21 04:17 PM
Bancel StephaneChief Executive OfficerSep 16Sale431.3010,0004,313,0007,234,880Sep 17 05:23 PM
Andres JuanSee remarksSep 15Option Exercise12.215,00061,0505,000Sep 17 05:26 PM
Bancel StephaneChief Executive OfficerSep 15Sale427.139,0003,844,1706,100,868Sep 17 05:23 PM
Andres JuanSee remarksSep 15Sale427.135,0002,135,6500Sep 17 05:26 PM
Hoge StephenPresidentSep 13Option Exercise5.9520,000118,9001,629,597Sep 14 04:15 PM
Andres JuanSee remarksSep 13Option Exercise12.2115,000183,15015,000Sep 14 04:20 PM
Hoge StephenPresidentSep 13Sale447.4120,0008,948,2001,609,597Sep 14 04:15 PM
Andres JuanSee remarksSep 13Sale447.4115,0006,711,1500Sep 14 04:20 PM
Andres JuanSee remarksSep 10Option Exercise12.215,00061,0505,000Sep 14 04:20 PM
Andres JuanSee remarksSep 10Sale461.855,0002,309,2500Sep 14 04:20 PM
Bancel StephaneChief Executive OfficerSep 09Sale429.9910,0004,299,9007,244,880Sep 10 04:14 PM
Andres JuanSee remarksSep 08Option Exercise12.215,00061,0505,000Sep 09 04:23 PM
Bancel StephaneChief Executive OfficerSep 08Sale433.729,0003,903,4806,113,868Sep 10 04:14 PM
Andres JuanSee remarksSep 08Sale433.725,0002,168,6000Sep 09 04:23 PM
Andres JuanSee remarksSep 07Option Exercise12.215,00061,0505,000Sep 09 04:23 PM
Andres JuanSee remarksSep 07Sale409.595,0002,047,9500Sep 09 04:23 PM
Hoge StephenPresidentSep 03Option Exercise0.9910,0009,9001,619,597Sep 07 04:18 PM
Andres JuanSee remarksSep 03Option Exercise12.215,00061,0505,000Sep 07 04:24 PM
Hoge StephenPresidentSep 03Sale392.3510,0003,923,5001,609,597Sep 07 04:18 PM
Andres JuanSee remarksSep 03Sale392.355,0001,961,7500Sep 07 04:24 PM
Hoge StephenPresidentSep 02Option Exercise0.9910,0009,9001,619,597Sep 03 08:58 AM
Hoge StephenPresidentSep 02Sale393.1310,0003,931,3001,609,597Sep 03 08:58 AM
Bancel StephaneChief Executive OfficerSep 02Sale393.1310,0003,931,3007,254,880Sep 03 09:04 AM
Andres JuanSee remarksSep 01Option Exercise12.215,00061,0505,000Sep 03 08:56 AM
Andres JuanSee remarksSep 01Sale381.825,0001,909,1000Sep 03 08:56 AM
Bancel StephaneChief Executive OfficerSep 01Sale381.829,0003,436,3806,126,868Sep 03 09:04 AM
Andres JuanSee remarksAug 30Option Exercise12.2115,000183,15015,000Aug 31 04:49 PM
Andres JuanSee remarksAug 30Sale368.9315,0005,533,9500Aug 31 04:49 PM
Andres JuanSee remarksAug 27Option Exercise12.215,00061,0505,000Aug 31 04:49 PM
Andres JuanSee remarksAug 27Sale398.125,0001,990,6000Aug 31 04:49 PM
Bancel StephaneChief Executive OfficerAug 26Sale395.4510,0003,954,5007,264,880Aug 27 04:36 PM
Andres JuanSee remarksAug 25Option Exercise12.215,00061,0505,000Aug 27 04:40 PM
Bancel StephaneChief Executive OfficerAug 25Sale391.599,0003,524,3106,139,868Aug 27 04:36 PM
Andres JuanSee remarksAug 25Sale391.595,0001,957,9500Aug 27 04:40 PM
Hoge StephenPresidentAug 24Option Exercise10.905,00054,5001,614,597Aug 25 04:20 PM
Hoge StephenPresidentAug 24Sale403.985,0002,019,9001,609,597Aug 25 04:20 PM
Hoge StephenPresidentAug 23Option Exercise4.2915,00064,4001,624,597Aug 25 04:20 PM
Andres JuanSee remarksAug 23Option Exercise12.215,00061,0505,000Aug 24 04:29 PM
Hoge StephenPresidentAug 23Sale398.8515,0005,982,7631,609,597Aug 25 04:20 PM
Andres JuanSee remarksAug 23Sale390.115,0001,950,5500Aug 24 04:29 PM
Andres JuanSee remarksAug 20Option Exercise12.215,00061,0505,000Aug 24 04:29 PM
Andres JuanSee remarksAug 20Sale374.885,0001,874,4000Aug 24 04:29 PM
Bancel StephaneChief Executive OfficerAug 19Sale385.0010,0003,850,0007,274,880Aug 20 09:12 AM
Andres JuanSee remarksAug 18Option Exercise12.215,00061,0505,000Aug 20 09:17 AM
Bancel StephaneChief Executive OfficerAug 18Sale407.009,0003,663,0006,152,868Aug 20 09:12 AM
Andres JuanSee remarksAug 18Sale407.005,0002,035,0000Aug 20 09:17 AM
Andres JuanSee remarksAug 16Option Exercise12.2115,000183,15015,000Aug 18 04:48 PM
Andres JuanSee remarksAug 16Sale379.2715,0005,689,0500Aug 18 04:48 PM
Andres JuanSee remarksAug 13Option Exercise12.215,00061,0505,000Aug 16 04:58 PM
Hoge StephenPresidentAug 13Option Exercise4.2915,00064,4001,624,597Aug 16 05:03 PM
Andres JuanSee remarksAug 13Sale405.005,0002,025,0000Aug 16 04:58 PM
Hoge StephenPresidentAug 13Sale405.0015,0006,075,0001,609,597Aug 16 05:03 PM
Hoge StephenPresidentAug 12Option Exercise10.905,00054,5001,614,597Aug 16 05:03 PM
Hoge StephenPresidentAug 12Sale400.005,0002,000,0001,609,597Aug 16 05:03 PM
Bancel StephaneChief Executive OfficerAug 12Sale400.0010,0004,000,0007,284,880Aug 13 04:07 PM
Andres JuanSee remarksAug 11Option Exercise12.215,00061,0505,000Aug 13 04:10 PM
Bancel StephaneChief Executive OfficerAug 11Sale443.349,0003,990,0606,165,868Aug 13 04:07 PM
Andres JuanSee remarksAug 11Sale443.345,0002,216,7000Aug 13 04:10 PM
Andres JuanSee remarksAug 09Option Exercise12.215,00061,0505,000Aug 10 04:18 PM
Andres JuanSee remarksAug 09Sale411.505,0002,057,5000Aug 10 04:18 PM
Andres JuanSee remarksAug 06Option Exercise12.215,00061,0505,000Aug 10 04:18 PM
Andres JuanSee remarksAug 06Sale410.305,0002,051,5000Aug 10 04:18 PM
Bancel StephaneChief Executive OfficerAug 05Sale410.0010,0004,100,0007,294,880Aug 06 09:04 AM
Andres JuanSee remarksAug 04Option Exercise12.215,00061,0505,000Aug 06 09:05 AM
Andres JuanSee remarksAug 04Sale384.855,0001,924,2500Aug 06 09:05 AM
Bancel StephaneChief Executive OfficerAug 04Sale384.859,0003,463,6506,178,868Aug 06 09:04 AM
Hoge StephenPresidentAug 03Option Exercise0.9910,0009,9001,619,597Aug 04 04:23 PM
Hoge StephenPresidentAug 03Sale348.7710,0003,487,7001,609,597Aug 04 04:23 PM
Andres JuanSee remarksAug 02Option Exercise12.2115,000183,15015,000Aug 03 04:23 PM
Hoge StephenPresidentAug 02Option Exercise0.9910,0009,9001,619,597Aug 04 04:23 PM
Andres JuanSee remarksAug 02Sale360.1515,0005,402,2500Aug 03 04:23 PM
Hoge StephenPresidentAug 02Sale360.1510,0003,601,5001,609,597Aug 04 04:23 PM
Andres JuanSee remarksJul 30Option Exercise12.215,00061,0505,000Aug 03 04:23 PM
Andres JuanSee remarksJul 30Sale346.905,0001,734,5000Aug 03 04:23 PM
Bancel StephaneChief Executive OfficerJul 29Sale351.0010,0003,510,0007,304,880Jul 30 04:31 PM
Andres JuanSee remarksJul 28Option Exercise12.215,00061,0505,000Jul 30 04:28 PM
Andres JuanSee remarksJul 28Sale332.925,0001,664,6000Jul 30 04:28 PM
Bancel StephaneChief Executive OfficerJul 28Sale332.929,0002,996,2806,191,868Jul 30 04:31 PM
Andres JuanSee remarksJul 26Option Exercise12.215,00061,0505,000Jul 27 05:29 PM
Hoge StephenPresidentJul 26Option Exercise10.905,00054,5001,614,597Jul 27 06:14 PM
Andres JuanSee remarksJul 26Sale351.995,0001,759,9500Jul 27 05:29 PM
Hoge StephenPresidentJul 26Sale351.995,0001,759,9501,609,597Jul 27 06:14 PM
Andres JuanSee remarksJul 23Option Exercise12.215,00061,0505,000Jul 27 05:29 PM
Hoge StephenPresidentJul 23Option Exercise4.2915,00064,4001,624,597Jul 27 06:14 PM
Andres JuanSee remarksJul 23Sale330.905,0001,654,5000Jul 27 05:29 PM
Hoge StephenPresidentJul 23Sale335.1315,0005,026,9551,609,597Jul 27 06:14 PM
Bancel StephaneChief Executive OfficerJul 22Sale318.5010,0003,185,0007,314,880Jul 23 09:27 AM
Andres JuanSee remarksJul 21Option Exercise12.215,00061,0505,000Jul 23 09:28 AM
Bancel StephaneChief Executive OfficerJul 21Sale299.009,0002,691,0006,204,868Jul 23 09:27 AM
Andres JuanSee remarksJul 21Sale299.005,0001,495,0000Jul 23 09:28 AM
Andres JuanSee remarksJul 19Option Exercise12.2115,000183,15015,000Jul 20 04:15 PM
Andres JuanSee remarksJul 19Sale284.4015,0004,266,0000Jul 20 04:15 PM